FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2320992886> ?p ?o ?g. }

• W2320992886 endingPage "258" @default.
• W2320992886 startingPage "241" @default.
• W2320992886 abstract "The use of insulin analogs for the treatment of type 1 diabetes mellitus (T1DM) is widespread; however, the therapeutic benefits still require further evaluation given their higher costs. The objective of this study was to evaluate the effectiveness and safety of analog insulin glargine compared to recombinant DNA (rDNA) insulin in patients with T1DM in observational studies, building on previous reviews of randomized controlled trials comparing neutral protamine Hagedorn insulin and insulin glargine.A systematic review with a meta-analysis was performed. The review included cohort studies and registries available on PubMed, LILACS, and the Cochrane Central Register of Controlled Trials (CENTRAL), as well as manual and gray literature searches. The meta-analysis was conducted in Review Manager 5.3 software. The primary outcomes were glycated hemoglobin (Hb1Ac), weight gain, and hypoglycemia. Methodological quality was assessed using the Newcastle-Ottawa scale.Out of 796 publications, 11 studies were finally included. The meta-analysis favored insulin glargine in HbA1c outcomes (adult patients) and hypoglycemic episodes (P < 0.05), but without reaching glycemic control (Hb1Ac to approximately 7%). The methodological quality of the studies was moderate, noting that 45% of studies were funded by pharmaceutical companies.Given the high heterogeneity of the studies, the discrete value presented by the estimated effect on effectiveness and safety, potential conflicts of interest of the studies, and the appreciable higher cost of insulin glargine, there is still no support for recommending first-line therapy with analogs. The role of analogs in the treatment of T1DM could be better determined by further observational studies of good methodological quality to assess their long-term effectiveness and safety, as well as their cost-effectiveness." @default.
• W2320992886 created "2016-06-24" @default.
• W2320992886 creator A5006284680 @default.
• W2320992886 creator A5015045982 @default.
• W2320992886 creator A5023743627 @default.
• W2320992886 creator A5028480298 @default.
• W2320992886 creator A5029445257 @default.
• W2320992886 creator A5071717298 @default.
• W2320992886 creator A5072350377 @default.
• W2320992886 creator A5087893304 @default.
• W2320992886 date "2016-04-05" @default.
• W2320992886 modified "2023-10-10" @default.
• W2320992886 title "Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis" @default.
• W2320992886 cites W1915612727 @default.
• W2320992886 cites W1960751741 @default.
• W2320992886 cites W1969683258 @default.
• W2320992886 cites W1973288625 @default.
• W2320992886 cites W1979423827 @default.
• W2320992886 cites W2000156950 @default.
• W2320992886 cites W2010274163 @default.
• W2320992886 cites W2016300030 @default.
• W2320992886 cites W2022473733 @default.
• W2320992886 cites W2024571159 @default.
• W2320992886 cites W2028432936 @default.
• W2320992886 cites W2029862269 @default.
• W2320992886 cites W2036044133 @default.
• W2320992886 cites W2044066734 @default.
• W2320992886 cites W2050560655 @default.
• W2320992886 cites W2051503793 @default.
• W2320992886 cites W2054294193 @default.
• W2320992886 cites W2058777107 @default.
• W2320992886 cites W2080393128 @default.
• W2320992886 cites W2081135787 @default.
• W2320992886 cites W2084539330 @default.
• W2320992886 cites W2097158472 @default.
• W2320992886 cites W2102950278 @default.
• W2320992886 cites W2109663791 @default.
• W2320992886 cites W2110590807 @default.
• W2320992886 cites W2122798076 @default.
• W2320992886 cites W2134413272 @default.
• W2320992886 cites W2143962486 @default.
• W2320992886 cites W2158144637 @default.
• W2320992886 cites W2319952518 @default.
• W2320992886 cites W2472989630 @default.
• W2320992886 cites W2588681363 @default.
• W2320992886 cites W37176890 @default.
• W2320992886 cites W4210559565 @default.
• W2320992886 doi "https://doi.org/10.1007/s13300-016-0166-y" @default.
• W2320992886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4900976" @default.
• W2320992886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27048292" @default.
• W2320992886 hasPublicationYear "2016" @default.
• W2320992886 type Work @default.
• W2320992886 sameAs 2320992886 @default.
• W2320992886 citedByCount "20" @default.
• W2320992886 countsByYear W23209928862016 @default.
• W2320992886 countsByYear W23209928862017 @default.
• W2320992886 countsByYear W23209928862018 @default.
• W2320992886 countsByYear W23209928862019 @default.
• W2320992886 countsByYear W23209928862020 @default.
• W2320992886 countsByYear W23209928862021 @default.
• W2320992886 countsByYear W23209928862022 @default.
• W2320992886 countsByYear W23209928862023 @default.
• W2320992886 crossrefType "journal-article" @default.
• W2320992886 hasAuthorship W2320992886A5006284680 @default.
• W2320992886 hasAuthorship W2320992886A5015045982 @default.
• W2320992886 hasAuthorship W2320992886A5023743627 @default.
• W2320992886 hasAuthorship W2320992886A5028480298 @default.
• W2320992886 hasAuthorship W2320992886A5029445257 @default.
• W2320992886 hasAuthorship W2320992886A5071717298 @default.
• W2320992886 hasAuthorship W2320992886A5072350377 @default.
• W2320992886 hasAuthorship W2320992886A5087893304 @default.
• W2320992886 hasBestOaLocation W23209928861 @default.
• W2320992886 hasConcept C126322002 @default.
• W2320992886 hasConcept C134018914 @default.
• W2320992886 hasConcept C168563851 @default.
• W2320992886 hasConcept C17744445 @default.
• W2320992886 hasConcept C177713679 @default.
• W2320992886 hasConcept C189708586 @default.
• W2320992886 hasConcept C199539241 @default.
• W2320992886 hasConcept C23131810 @default.
• W2320992886 hasConcept C2777180221 @default.
• W2320992886 hasConcept C2777538456 @default.
• W2320992886 hasConcept C2779306644 @default.
• W2320992886 hasConcept C2779473830 @default.
• W2320992886 hasConcept C2779920387 @default.
• W2320992886 hasConcept C2780473172 @default.
• W2320992886 hasConcept C2780668416 @default.
• W2320992886 hasConcept C2781232474 @default.
• W2320992886 hasConcept C555293320 @default.
• W2320992886 hasConcept C71924100 @default.
• W2320992886 hasConcept C95190672 @default.
• W2320992886 hasConceptScore W2320992886C126322002 @default.
• W2320992886 hasConceptScore W2320992886C134018914 @default.
• W2320992886 hasConceptScore W2320992886C168563851 @default.
• W2320992886 hasConceptScore W2320992886C17744445 @default.
• W2320992886 hasConceptScore W2320992886C177713679 @default.
• W2320992886 hasConceptScore W2320992886C189708586 @default.
• W2320992886 hasConceptScore W2320992886C199539241 @default.

• next